Overview

Dr. Charles Staley joined the Emory faculty in 1995 after completing his surgical oncology fellowship at MD Anderson Cancer Center. His clinical practice focuses on surgical treatment of stomach, esophageal, appendiceal, colorectal, pancreas, liver cancer, and peritoneal surface malignancies. His research focuses on translational studies and novel clinical trials in gastrointestinal cancers. He has investigated gene therapy for metastatic colon cancer, radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases, and neoadjuvant chemoradiation with the goal of maximizing sphincter preservation in the treatment of rectal cancer. His current investigations include exploring methods of using nanotechnology to diagnose and treat pancreatic and breast cancer with such colleagues as Dr. Lily Yang.

Dr. Staley coordinates national efforts for clinical cancer research as a principle investigator for clinical trials for the Eastern Cooperative Oncology Group; as chair of the Vizient UHC Cancer Center Network Steering Committee, which oversees a national network of approximately 125 cancer centers nationally; and as co-principal investigator of the Winship Cancer Institute location of the National Cancer Institute's National Clinical Trials Network (NCTN). The NCTN serves as the NCI's primary infrastructure for conducting phase II and phase III cancer clinical trials.

Academic Appointment

• Holland M. Ware Professor of Surgery, Emory University School of Medicine
• Professor of Surgery, Emory University School of Medicine

Education

Research